Éric Mascard

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

Sophie Piperno‐Neumann, Marie‐Cécile Le Deley, Françoise Rédiní et al. · The Lancet Oncology · 2016 · 201 citations

Surgical Oncology, Medicine, Metronomic Therapy +7

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Anne Gomez‐Brouchet, Claire Illac, Julia Gilhodes et al. · OncoImmunology · 2017 · 165 citations · Full text

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

Nathalie Gaspar, Bob‐Valéry Occéan, Hélène Pacquement et al. · European Journal of Cancer · 2017 · 138 citations

Surgical Oncology, Osteosarcoma Patients, Medicine +9

Intralesional Ethibloc injections in primary aneurysmal bone cysts: an efficient and safe treatment

C. Adamsbaum, Éric Mascard, Jean Marc Guinebreti�re et al. · Skeletal Radiology · 2003 · 106 citations

Safe Treatment, Intralesional Ethibloc Injections, Surgery +2

Retroversion of the Acetabular Dome after Salter and Triple Pelvic Osteotomy for Congenital Dislocation of the Hip

Claudio Dora, Éric Mascard, Kiril Mladenov et al. · Journal of Pediatric Orthopaedics B · 2002 · 85 citations

Thumb Hypoplasia, Hip Arthroplasty, Osteoarthritis +14